Outline
Oxford-AstraZeneca Vaccine for COVID-19: A Case Report: COVID-19
Authors
Abstract
The design and development of a vaccine against the new coronavirus obtain an important goal of the global health community, which has developed and approved several vaccines, including the Oxford-AstraZeneca vaccine. The vaccine has been challenged because of reports of side effects after vaccination, while the level of immunity created by the vaccine has been confirmed. In this study, we examined the complication and change in laboratory tests of hematology, biochemistry, and enzymology in a 42-year-old woman with no history of specific disease after receiving the Oxford-AstraZeneca vaccine for 7 days. Our studies showed that following the injection of the vaccine, platelet, RBC, WBC decreased, and increased D-Dimer rates. Also that the standard rate has changed between Neutrophil, Lymphocyte, and Monocyte. There is evidence of Prothrombotic Immune Thrombocytopenia and following that there is a risk of the embolism, but the particular point is that this complication is temporary and the test process is progressing towards recovery.
References
- 1.References are in the PDF file of the article.
Copyright
© 2021, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Spontaneous Subarachnoid Haemorrhage After COVID-19 Vaccination; a Rare Case Report
Abdollahi M, Alidaei N, Ayar A. Spontaneous Subarachnoid Haemorrhage After COVID-19 Vaccination; a Rare Case Report. Arch Clin Infect Dis. 2022;17(5):e127354. doi: https://doi.org/10.5812/archcid-127354
A Comparison of Adverse Reactions of the First Dose of Gam-COVID-vac (Sputnik V), Oxford/AstraZeneca COVID-19 Vaccine, Bharat Biotech (Covaxin), and (Sinopharm) BBIBP-CorV Vaccines
Samimagham H, Hassani Azad M, Arabi M, Montazer Ghaem S, Jafari K, et al. A Comparison of Adverse Reactions of the First Dose of Gam-COVID-vac (Sputnik V), Oxford/AstraZeneca COVID-19 Vaccine, Bharat Biotech (Covaxin), and (Sinopharm) BBIBP-CorV Vaccines. J Health Rep Technol. 2022;8(4):e122479. doi: https://doi.org/10.5812/jhrt-122479
Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Glomerulonephritis in a 15-Year-Old Patient After Receiving the Second Dose of the BBIBP-CorV (Sinopharm) COVID-19 Vaccine: A Case Report
Ramezanzade E, Ghanbari R, Yazdanipour T. Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Glomerulonephritis in a 15-Year-Old Patient After Receiving the Second Dose of the BBIBP-CorV (Sinopharm) COVID-19 Vaccine: A Case Report. Nephro-Urol Mon. 2022;14(3):e127124. doi: https://doi.org/10.5812/numonthly-127124
The Alteration of Clinical and Laboratory Signs and Symptoms of COVID-19 in Re-infection: A Case Report
yekefallah L, Namdar P, mohammadi S. The Alteration of Clinical and Laboratory Signs and Symptoms of COVID-19 in Re-infection: A Case Report. J Inflamm Dis. 2024;25(1):e156265. doi:
Vaccination Against COVID-19 in Comorbid Patients
Ashirova Ashirova M, Abuova GN, Shaimerdenova GG. Vaccination Against COVID-19 in Comorbid Patients. Arch Clin Infect Dis. 2025;20(1):e148021. doi: https://doi.org/10.5812/archcid-148021
- Scopus by DOI: 0
Last Update: 1 month ago
- Scopus by Title: 0
Last Update: 1 month ago
- Scopus by Title (Ref): 0
Last Update: 1 month ago
- CrossRef: 0
Last Update: 3 days ago